首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS, METHOD FOR PREVENTING OR TREATING DIABETES MELLITUS, AND METHOD FOR SCREENING FOR DIABETES MELLITUS THERAPEUTIC AGENT

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS, METHOD FOR PREVENTING OR TREATING DIABETES MELLITUS, AND METHOD FOR SCREENING FOR DIABETES MELLITUS THERAPEUTIC AGENT

机译:用于预防或治疗糖尿病的药物组合物,用于预防或治疗糖尿病的方法以及用于筛查糖尿病的治疗剂的方法

摘要

Provided are a pharmaceutical composition including geraniol or a pharmaceutically acceptable salt thereof as an active ingredient for use in preventing or treating diabetes mellitus, a method of preventing or treating diabetes mellitus or a complication due to diabetes mellitus of an individual, in which the method includes administering the individual with a pharmaceutical composition comprising geraniol or a pharmaceutically acceptable salt thereof as an active ingredient and inducing an olfactory stimulation to the individual using the pharmaceutical composition, and a screening method of an antidiabetic agent that may include contacting a cell expressing an olfactory receptor with a test material; measuring a level of expression of glucagon-like peptide-1 (GLP-1) secreted from the cell; and determining the test material, when the test material promotes expression of GLP-1, as a candidate material of an antidiabetic agent. In addition, a quasi-drug composition and a cosmetic composition including geraniol for uses are provided.
机译:提供了包含香叶醇或其药学上可接受的盐作为用于预防或治疗糖尿病的活性成分的药物组合物,预防或治疗糖尿病的方法或个体的糖尿病引起的并发症,其中该方法包括:给个体施用包含香叶醇或其药学上可接受的盐作为活性成分的药物组合物,并使用该药物组合物对个体诱导嗅觉刺激,以及抗糖尿病药的筛选方法,该方法可以包括使表达嗅觉受体的细胞接触带有测试材料;测量从细胞分泌的胰高血糖素样肽-1(GLP-1)的表达水平;当测试材料促进GLP-1表达时,确定测试材料作为抗糖尿病药的候选材料。另外,提供了准用途的药物组合物和包含香叶醇的化妆品组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号